Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Sublingual immunotherapy for aeroallergens: status in the United States.

Cox L.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):34-42. doi: 10.2500/aap.2014.35.3708. Review.

PMID:
24433595
2.

Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy.

Larenas-Linnemann DE, Mösges R.

Allergy Asthma Proc. 2016 Jan-Feb;37(1):50-6. doi: 10.2500/aap.2016.37.3907.

PMID:
26831847
3.

Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States.

Epstein TG, Calabria C, Cox LS, Dreborg S.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):34-40.e2. doi: 10.1016/j.jaip.2016.09.017. Epub 2016 Nov 1. Review.

PMID:
27815065
4.

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

Calderon MA, Casale TB, Nelson HS, Demoly P.

J Allergy Clin Immunol. 2013 Dec;132(6):1322-36. doi: 10.1016/j.jaci.2013.09.004. Epub 2013 Oct 18. Review.

PMID:
24139829
5.

Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.

Dranitsaris G, Ellis AK.

J Eval Clin Pract. 2014 Jun;20(3):225-38. doi: 10.1111/jep.12112. Epub 2014 Jan 21. Review.

PMID:
24444390
6.

Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.

Nelson HS.

Expert Rev Clin Immunol. 2014 Nov;10(11):1437-51. doi: 10.1586/1744666X.2014.963556. Review.

PMID:
25340426
7.

Selection of patients for sublingual versus subcutaneous immunotherapy.

Larenas Linnemann DE, Blaiss MS.

Immunotherapy. 2014;6(7):871-84. doi: 10.2217/imt.14.55. Review.

PMID:
25290418
8.

Sublingual immunotherapy: the U.S. experience.

Nelson HS.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):663-8. doi: 10.1097/ACI.0b013e328364580e. Review.

PMID:
24169432
9.

Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.

Larenas-Linnemann D, Esch R, Plunkett G, Brown S, Maddox D, Barnes C, Constable D.

Ann Allergy Asthma Immunol. 2011 Nov;107(5):448-458.e3. doi: 10.1016/j.anai.2011.07.001. Epub 2011 Aug 30.

PMID:
22018618
10.

Sublingual Immunotherapy for the Polyallergic Patient.

Pepper AN, Calderón MA, Casale TB.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):41-45. doi: 10.1016/j.jaip.2016.06.019. Epub 2016 Jul 21. Review.

PMID:
27452888
11.

Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.

Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G.

JAMA Intern Med. 2015 Aug;175(8):1301-9. doi: 10.1001/jamainternmed.2015.2840. Review.

PMID:
26120825
12.
13.

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.

Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken MP.

J Allergy Clin Immunol. 2013 Aug;132(2):353-60.e2. doi: 10.1016/j.jaci.2013.03.013. Epub 2013 May 4.

PMID:
23651609
14.

Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?

Nelson HS.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):144-9; quiz 150-1. doi: 10.1016/j.jaip.2013.11.018. Review.

PMID:
24607040
15.

Sublingual immunotherapy: current concepts for the U.S. practitioner.

Lin SY.

Int Forum Allergy Rhinol. 2014 Sep;4 Suppl 2:S55-9. doi: 10.1002/alr.21388. Review.

PMID:
25182357
16.

Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.

Manzotti G, Pappacoda A, Dimatteo M, Scolari C, Riario-Sforza GG, Incorvaia C.

Eur Ann Allergy Clin Immunol. 2013 Aug 1;45(4):138-43.

PMID:
24067339
17.

Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.

Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G.

J Allergy Clin Immunol. 2012 Nov;130(5):1097-1107.e2. doi: 10.1016/j.jaci.2012.08.012. Epub 2012 Sep 27.

PMID:
23021885
18.

Sublingual or subcutaneous immunotherapy for allergic rhinitis?

Durham SR, Penagos M.

J Allergy Clin Immunol. 2016 Feb;137(2):339-349.e10. doi: 10.1016/j.jaci.2015.12.1298. Review.

PMID:
26853126
19.

Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.

Esch RE, Bush RK, Peden D, Lockey RF.

Ann Allergy Asthma Immunol. 2008 May;100(5):475-81. doi: 10.1016/S1081-1206(10)60474-7.

PMID:
18517081
20.

Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.

Li JT, Bernstein DI, Calderon MA, Casale TB, Cox L, Passalacqua G, Pfaar O, Papadopoulos NG.

J Allergy Clin Immunol. 2016 Feb;137(2):369-76. doi: 10.1016/j.jaci.2015.06.046. Epub 2015 Sep 12. Review.

PMID:
26371843

Supplemental Content

Support Center